Despite the high stakes of data vulnerabilities to the entire healthcare system, governments in Asia lag behind in mandating cybersecurity measures, leaving manufacturers to install and maintain systems to protect against cyber criminals.
Before accepting money, the following is a guide to your due diligence process.
Earlier this year, the CFDA introduced significant changes to the drug and device approval process.
Companies must be aware of the changing clinical trial regulatory environment for devices in China.
In lieu of trials, some companies may be able to submit a CER.
How do the latest requirements affect your business?